No Detail Found!

Comparative evaluation of intrathecal hyperbaric bupivacaine alone versus combined with dexmedetomidine for cesarean sections

Author(s)
Rida Amjad Qureshi Department of Anesthesiology, Pain & Intensive Care, KRL Hospital,G9/1, Islamabad,Pakistan
Humaira Jadoon Department of Anesthesiology, Pain & Intensive Care, KRL Hospital,G9/1, Islamabad,Pakistan
Mahnoor Shabbir Department of Anesthesiology, Pain & Intensive Care, Galway University Hospital,,Ireland
Abstract
Background & Objective: This study examined the use of dexmedetomidine 5 µg as an adjuvant to 10 mg of intrathecal hyperbaric 0.5% bupivacaine in elective cesarean sections and aimed to assess dexmedetomidine's impact on block characteristics and post-operative pain management. As spinal anesthesia is commonly employed for cesarean deliveries, the study seeks to determine whether the addition of dexmedetomidine as an adjuvant can prolong the duration and enhance the quality of the block, leading to improved post-operative pain relief. Methodology: This randomized controlled trial included 100 parturients undergoing elective cesarean section over a period of six months. Participants were allocated to either Group B or Group D using a non-random consecutive sampling technique. In Group D, 2 mL of 0.5% bupivacaine mixed with 0.05 mL of dexmedetomidine (5µg) was injected intrathecally, while Group B received 2 mL of 0.5% hyperbaric bupivacaine along with an equivalent volume of saline. Sensory and motor block assessments were conducted prior to the start of surgery. Post-operatively, the duration of motor block and post-operative pain relief were assessed. Results: The addition of dexmedetomidine as an adjuvant to intrathecal bupivacaine resulted in significant reductions in the onset time of sensory block (4.22 ± 0.79 min vs 5.66 ± 1.21 min) and motor block (4.20 ± 0.81min vs 6.32 ± 1.20 min) (P < 0.001). Furthermore, the duration of motor block was longer in the dexmedetomidine + bupivacaine group compared to the bupivacaine alone group (7.32 ± 0.95 h vs 4.38 ± 1.27 h). Additionally, patients who received intrathecal dexmedetomidine as an adjuvant to bupivacaine experienced significantly longer durations of post-operative analgesia (7.32 ± 0.95 h) as compared to the bupivacaine alone group (4.38 ± 1.27 h) (P < 0.001). Conclusion: Dexmedetomidine as an intrathecal adjuvant to hyperbaric bupivacaine extends the duration of analgesia and motor block, providing prolonged pain relief. Additionally, it exhibits an early onset of sensory and motor block, ensuring prompt pain relief and rapid anesthesia onset. Clinical Trial Registration: [www.clinicaltrials.gov], identifier: ID NCT05469529 Abbreviations: CS - cesarean section; OT - Operation Theater; SA - Spinal anesthesia; VAS - visual analogue scale;
Publication Details
Page(s) 866-870
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 28, Issue: 5, Year: 2024

Request the full text from PASTIC

Keywords
Bupivacaine, Cesarean section, Spinal anesthesia, Dexmedetomidine
References
Amjad A,Imran A,Shahram N,Zakar R,Usman A,Zakar MZ .2020 .Trends of caesarean section deliveries in Pakistan: secondary data analysis from Demographic and Health Surveys,. , 20(1) : 753.
. .. , : .
Cureus .2018 .. , 10(12) : .
.2018 .Comparison between general, spinal, epidural, and combined spinal-epidural anesthesia for cesarean delivery: a network meta-analysis. Int J Obstet Anesth, 09 : 5-15.
Amin OAI,Ibrahem MA,Salem DAE .2020 .Nalbuphine versus midazolam as an adjuvant to intrathecal bupivacaine for postoperative analgesia in patients undergoing cesarean section. J Pain Res, 13 : 1369-76.
.2019 .. , 23(3) : 348-54.
.2022 .. , 06(5) : 627-33.
Gertler R,Brown HC,Mitchell DH,Silvius EN .2001 .Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent), 14(1) : 13-21.
Alam SS,Abbas N,Asgher A,Rafique M,Anees ur R,Abid K.,- K. .2022 .Effectiveness of intrathecal dexmedetomidine in combination with hyperbaric bupivacaine for lower abdominal surgeries and its postoperative analgesic characteristic. J Ayub Med Coll Abbottabad, 34(Suppl 1) : S936-S939.
Azemati S,Zarghami A,Jouybar R,Naderi-Boldaji V .2022 .Analgesic characteristics of bupivacaine alone and in combination with dexmedetomidine or meperidine in spinal anesthesia during cesarean section: a double-blind randomized clinical trial study. Pain Res Manag, : 5111214.
Sun Y,Xu Y,Wang GN .2015 .Comparative evaluation of intrathecal bupivacaine alone, bupivacaine-fentanyl, and bupivacainedexmedetomidine in caesarean section. Drug Res (Stuttg), 65(9) : 468-72.
Kalbande JV,Deotale KD,Karim N AK,HMR N AK .2022 .Addition of dexmedetomidine and fentanyl to intrathecal hyperbaric bupivacaine for lower limb surgeries: a randomized, comparative study. Cureus, 14(8) : .
Zhang Q,Xia LY,Liang WD,Rao DY,Zhu PP,Huang KN .2022 .Intrathecal dexmedetomidine combined with ropivacaine in cesarean section: A Prospective Randomized Double-Blind Controlled Study. Front Med (Lausanne), 9 : 922611.
0

Citations

0

Downloads

38

Views